Effects of Different Flow Anesthesia on Atelectasis

• Sponsor: Zonguldak Bulent Ecevit University (Other)
• Overall Status: Completed
• CT.gov ID: NCT05381701
• Collaborator: (none)
• Enrollment: 1
• Location: 1
• Actual Duration (Months): 12
• Patients Per Site Per Month: 0.1

Study Details

Study Description

Brief Summary

Evaluation of atelectasis that may be caused by different flow rate anesthesia applications during the operation with lung ultrasound score.

Condition or Disease	Intervention/Treatment	Phase
Atelectasis; Due to Anesthesia; General Anesthesia; Low- Flow Anesthesia; Minimal Flow Anesthesia	Procedure: Lung Ultrasound Score

Study Design

• Study Type: Observational
• Actual Enrollment: 1 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Evaluation Of Peroperative Atelectasis In Minimal, Low And Medium Flow Anesthesia By Lung Ultrasound Score
• Actual Study Start Date: Jan 1, 2021
• Actual Primary Completion Date: Dec 31, 2021
• Actual Study Completion Date: Dec 31, 2021

Arms and Interventions

Arm	Intervention/Treatment
Group I Minimal Flow Anesthesia (0.25L/dk oxygen, 0,25 L/min air)	Procedure: Lung Ultrasound Score; Measuring the atelectasis area by ultrasound guidance from 12 different regions of the lung
Group II Low Flow Anesthesia (0.5L/dk oxygen, 0,5 L/min air)	Procedure: Lung Ultrasound Score; Measuring the atelectasis area by ultrasound guidance from 12 different regions of the lung
Group III Medium Flow Anesthesia (1L/dk oxygen, 1 L/min air	Procedure: Lung Ultrasound Score; Measuring the atelectasis area by ultrasound guidance from 12 different regions of the lung

Outcome Measures

Primary Outcome Measures

1. assessment of lung ultrasound score [Change from Baseline and 30 minute after emergence]

   Effect of different flow anesthesia on lung ultrasound score

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 65 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• operation time 2-5 hours

• elective septoplasty and rhinoplasty

• ASA I-II

Exclusion Criteria:

• morbid obesity

• malignant hyperthermia

• opioid sensitivity

• alcohol or drug addiction

• congestive heart failure

• chronic obstructive pulmonary disease

• coronary artery disease

• anemia

• liver and kidney diseases

• pregnancy

• breast-feeding

• history of allergy to drugs used

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Zonguldak Bülent Ecevit University Faculty of Medicine	Zonguldak	Kozlu	Turkey	67600

Sponsors and Collaborators

• Zonguldak Bulent Ecevit University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Tugce Ozturk, Anesthesiologist, Zonguldak Bulent Ecevit University
• ClinicalTrials.gov Identifier: NCT05381701
• Other Study ID Numbers: 2020/25-6
• First Posted: May 19, 2022
• Last Update Posted: May 19, 2022
• Last Verified: May 1, 2022

• Individual Participant Data (IPD) Sharing Statement: Yes
• Plan to Share IPD: Yes
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Tugce Ozturk, Anesthesiologist, Zonguldak Bulent Ecevit University: Lung Ultrasound Score; Minimal Flow Anesthesia; Atelectasis
• Additional relevant MeSH terms: Pulmonary Atelectasis

Study Results

No Results Posted as of May 19, 2022